Imminent Approval of Novartis’ CAR-T Cell Therapy is a Long-awaited Win for the Industry and the World A frontrunner seems to have ultimately emerged in the race to bring the very first CAR-T cell therapy to market. For several months the two chief competitors and their drug candidates have been Novartis’ tisagenlecleucel-T and Kite Pharma’s […]